Human embryonic kidney 293 (HEK293) and mouse brain endothelial cells (bEnd3 for transfections; bEnd5 for hypoxia) were maintained in a humidified incubator (37°C and 5% CO2) in complete Dulbecco’s modified Eagle’s medium (DMEM, 4.5 g/L glucose; Mediatech, Inc., Herndon, VA) supplemented with 10% heat-inactivated fetal bovine serum (Atlanta Biologicals, Inc., Lawrenceville, GA) and penicillin (100 U/mL)/streptomycin (100 μg/mL). For hypoxia, the bEnd5 cells were plated in complete medium in a 60-mm dish at a density of 1.6 × 105 cells/well and allowed to attach overnight. The following morning, the cells were exposed to hypoxia (5% CO2, 1% O2, and 94% N2) in a humidified hypoxic chamber (Coy Laboratory Products, Inc., Grass Lake, MI) or were maintained in normal tissue culture conditions (5% CO2, 21% O2, and 74% N2) at 37°C. Twenty-four hours after initiation of hypoxia or normoxia, the cells were used to prepare total RNA (Qiagen, Inc., Valencia, CA).